USPTO Examiner ALVARADO JR NELSON LOUIS - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
16950585DRIVE MECHANISMNovember 2020October 2023Allow3510NoNo
17078579ANCHOR INSTRUMENTATION AND METHODSOctober 2020July 2023Allow3310NoNo
17000967ECHOGENIC BALLOON DILATION CATHETER AND BALLOON THEREOFAugust 2020July 2023Allow3510NoNo
16966546PUNCTURE SYSTEMJuly 2020April 2023Allow3310NoNo
16936334FLOATER BASED FLOW CONTROL DEVICE FOR GRAVITY IV SETSJuly 2020June 2023Allow3410NoNo
16932503IMPLANTABLE VENOUS ACCESS PORT WITH REMOTE PHYSIOLOGICAL MONITORING CAPABILITIESJuly 2020June 2023Allow3510YesNo
16962554Catheter SystemJuly 2020September 2023Abandon3820NoNo
16961762DRUG DELIVERY MECHANISMJuly 2020May 2023Allow3410NoNo
16961025A MEDICAMENT DELIVERY DEVICE WITH A REMOVABLE CAP AND LOCKING MEMBER FOR PREVENTING ACCIDENTAL ACTIVIATIONJuly 2020June 2023Allow3610NoNo
16959476INTRODUCER POSITIONING DEVICE FOR CONTROLLING A CATHETER SHAFTJuly 2020June 2023Allow3611NoNo
16959314MICRONEEDLE DELIVERY SYSTEM WITH ANCHORJune 2020August 2023Abandon3801NoNo
16908531INJECTION SYSTEM AND METHODJune 2020March 2023Allow3310NoNo
16954421AUTO-INJECTION DRUG DELIVERY DEVICEJune 2020July 2023Allow3720YesNo
16771151Drive Mechanism with Noise ReductionJune 2020January 2023Allow3210NoNo
16893896Device and Methods for Reducing Pressure in Muscle CompartmentsJune 2020April 2023Allow3511YesNo
16765311Drive Subassembly for a Drug Delivery DeviceMay 2020May 2023Allow3611NoNo
16860020DEVICES AND METHODS FOR CONDUIT DISTENTIONApril 2020March 2023Allow3410YesNo
16650213A NEEDLE DEVICE FOR SELECTIVE SUBCUTANEOUS FLUID INJECTIONMarch 2020February 2025Abandon5950NoNo
16800804MEDICAMENT INJECTOR AND INTERCHANGEABLE CARTRIDGES THEREFORFebruary 2020May 2023Allow3911NoNo
16619328SYRINGEDecember 2019May 2023Abandon4110NoNo
16597734FLOW STOP DEVICEOctober 2019March 2023Allow4110NoNo
16487152Disposable Absorbent Stoma Pad for GastrostomyAugust 2019March 2023Allow4320NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner ALVARADO JR, NELSON LOUIS - Prosecution Strategy Guide

Executive Summary

Examiner ALVARADO JR, NELSON LOUIS works in Art Unit 3783 and has examined 22 patent applications in our dataset. With an allowance rate of 81.8%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner ALVARADO JR, NELSON LOUIS's allowance rate of 81.8% places them in the 55% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ALVARADO JR, NELSON LOUIS receive 1.27 office actions before reaching final disposition. This places the examiner in the 15% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ALVARADO JR, NELSON LOUIS is 36 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +22.2% benefit to allowance rate for applications examined by ALVARADO JR, NELSON LOUIS. This interview benefit is in the 66% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 100.0% of cases where such amendments are filed. This entry rate is in the 100% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.